Search

William A. Craigo

Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
936
Issued Applications
383
Pending Applications
126
Abandoned Applications
445

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17980400 [patent_doc_number] => 20220346436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => ORALLY DISSOLVING FILMS [patent_app_type] => utility [patent_app_number] => 17/726121 [patent_app_country] => US [patent_app_date] => 2022-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/726121
ORALLY DISSOLVING FILMS Apr 20, 2022 Pending
Array ( [id] => 18550761 [patent_doc_number] => 20230248761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => Method for supporting normal blood calcium concentrations in mammals [patent_app_type] => utility [patent_app_number] => 17/722789 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/722789
Method for supporting normal blood calcium concentrations in mammals Apr 17, 2022 Pending
Array ( [id] => 20320028 [patent_doc_number] => 20250332116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => CARBON-BASED ANTI VIRAL NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/555389 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555389 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/555389
CARBON-BASED ANTI VIRAL NANOPARTICLES Apr 11, 2022 Abandoned
Array ( [id] => 18690980 [patent_doc_number] => 20230321158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/716892 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2009 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716892 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/716892
COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF Apr 7, 2022 Abandoned
Array ( [id] => 19232298 [patent_doc_number] => 20240189490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => ANTIMICROBIAL ELUTING AIRWAY DEVICES [patent_app_type] => utility [patent_app_number] => 18/553893 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553893 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553893
ANTIMICROBIAL ELUTING AIRWAY DEVICES Apr 7, 2022 Pending
Array ( [id] => 18690995 [patent_doc_number] => 20230321175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES [patent_app_type] => utility [patent_app_number] => 17/716189 [patent_app_country] => US [patent_app_date] => 2022-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12589 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716189 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/716189
ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES Apr 7, 2022 Abandoned
Array ( [id] => 17748044 [patent_doc_number] => 20220226247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL [patent_app_type] => utility [patent_app_number] => 17/715322 [patent_app_country] => US [patent_app_date] => 2022-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2561 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715322 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/715322
STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL Apr 6, 2022 Abandoned
Array ( [id] => 17748059 [patent_doc_number] => 20220226262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE [patent_app_type] => utility [patent_app_number] => 17/713856 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13860 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713856 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/713856
METHODS OF TREATING DOOSE SYNDROME USING FENFLURAMINE Apr 4, 2022 Abandoned
Array ( [id] => 17911246 [patent_doc_number] => 20220313641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE [patent_app_type] => utility [patent_app_number] => 17/713843 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/713843
SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE Apr 4, 2022 Abandoned
Array ( [id] => 18281905 [patent_doc_number] => 20230097377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => Biodegradable Implant Including Naltrexone [patent_app_type] => utility [patent_app_number] => 17/711910 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711910
Biodegradable implant including naltrexone Mar 31, 2022 Issued
Array ( [id] => 17836295 [patent_doc_number] => 20220273600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/699892 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699892 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699892
LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF Mar 20, 2022 Abandoned
Array ( [id] => 19140519 [patent_doc_number] => 20240139310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/279459 [patent_app_country] => US [patent_app_date] => 2022-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279459 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/279459
MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF Mar 8, 2022 Abandoned
Array ( [id] => 20348429 [patent_doc_number] => 20250345281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-13 [patent_title] => METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION) [patent_app_type] => utility [patent_app_number] => 18/278905 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278905 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/278905
METHODS FOR THE EXTRACTION OF DISPERSIBLE MICROCAPSULES (IMMUNOCONTRACEPTION) Feb 24, 2022 Abandoned
Array ( [id] => 19140332 [patent_doc_number] => 20240139108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE [patent_app_type] => utility [patent_app_number] => 18/547260 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547260 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/547260
ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE Feb 24, 2022 Abandoned
Array ( [id] => 19691229 [patent_doc_number] => 20250009774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM [patent_app_type] => utility [patent_app_number] => 18/547934 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547934 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/547934
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM Feb 22, 2022 Pending
Array ( [id] => 17640694 [patent_doc_number] => 20220168432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/675842 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675842 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675842
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES Feb 17, 2022 Abandoned
Array ( [id] => 17836363 [patent_doc_number] => 20220273668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => IRAK4 DEGRADERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/651201 [patent_app_country] => US [patent_app_date] => 2022-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/651201
IRAK4 degraders and uses thereof Feb 14, 2022 Issued
Array ( [id] => 17895345 [patent_doc_number] => 20220305007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => INJECTABLE FORMULATION [patent_app_type] => utility [patent_app_number] => 17/650822 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650822
INJECTABLE FORMULATION Feb 10, 2022 Abandoned
Array ( [id] => 18351014 [patent_doc_number] => 20230139125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE [patent_app_type] => utility [patent_app_number] => 17/912371 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8016 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912371 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912371
DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE Feb 2, 2022 Abandoned
Array ( [id] => 17609816 [patent_doc_number] => 20220152095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => ELECTROLYTE COMPOSITION AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/587463 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/587463
ELECTROLYTE COMPOSITION AND METHODS OF USE Jan 27, 2022 Pending
Menu